These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21491608)

  • 1. Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy.
    Fechete R; Heinzel A; Perco P; Mönks K; Söllner J; Stelzer G; Eder S; Lancet D; Oberbauer R; Mayer G; Mayer B
    Proteomics Clin Appl; 2011 Jun; 5(5-6):354-66. PubMed ID: 21491608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems biology: building a useful model from multiple markers and profiles.
    Mayer P; Mayer B; Mayer G
    Nephrol Dial Transplant; 2012 Nov; 27(11):3995-4002. PubMed ID: 23144070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data mining methods in Omics-based biomarker discovery.
    Zhang F; Chen JY
    Methods Mol Biol; 2011; 719():511-26. PubMed ID: 21370100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Novel biomarkers for diabetic nephropathy].
    Araki S
    Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics in gerontology: current applications and future aspects--a mini-review.
    Schiffer E; Mischak H; Zimmerli LU
    Gerontology; 2009; 55(2):123-37. PubMed ID: 19136815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the use of biomarkers of diabetic nephropathy.
    Jha JC; Jandeleit-Dahm KA; Cooper ME
    Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy.
    Zhang Y; Zhang Q
    Biochem Biophys Res Commun; 2009 May; 383(1):1-3. PubMed ID: 19303394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Potential therapeutic targets for diabetic nephropathy].
    Makino Y; Haneda M
    Nihon Rinsho; 2009 Aug; 67(8):1627-35. PubMed ID: 19768953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis.
    Aschauer C; Perco P; Heinzel A; Sunzenauer J; Oberbauer R
    PLoS One; 2017; 12(1):e0169518. PubMed ID: 28060893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.
    Rossing K
    Dan Med Bull; 2007 May; 54(2):79-98. PubMed ID: 17521525
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms of diabetic nephropathy--old buddies and newcomers part 2.
    Nawroth PP; Isermann B
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):667-72. PubMed ID: 20658437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of endothelial dysfunction and early therapeutic correction effectively restore renal function in type 2 diabetic nephropathy.
    Futrakul N; Butthep P
    Ren Fail; 2005; 27(4):493-4. PubMed ID: 16060141
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetic nephropathy: important pathophysiologic mechanisms.
    Soldatos G; Cooper ME
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S75-9. PubMed ID: 18994672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanism of diabetic nephropathy].
    Ohshiro Y; Takasu N
    Nihon Rinsho; 2006 May; 64(5):997-1003. PubMed ID: 16689387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular disease presentation in diabetic nephropathy.
    Heinzel A; Mühlberger I; Stelzer G; Lancet D; Oberbauer R; Martin M; Perco P
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv17-25. PubMed ID: 26209734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials and tribulations of new agents, novel biomarkers, and retarding renal progression.
    Levin A; Beaulieu MC
    J Am Soc Nephrol; 2011 Jun; 22(6):992-3. PubMed ID: 21617124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.